Consonance Capital

Consonance Capital Management as of June 30, 2018

Portfolio Holdings for Consonance Capital Management

Consonance Capital Management holds 29 positions in its portfolio as reported in the June 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spectrum Pharmaceuticals 9.4 $146M 7.0M 20.96
Puma Biotechnology (PBYI) 8.0 $124M 2.1M 59.15
Pacira Pharmaceuticals (PCRX) 7.8 $120M 3.8M 32.05
Retrophin 6.8 $105M 3.8M 27.26
Vanda Pharmaceuticals (VNDA) 5.7 $88M 4.6M 19.05
Karyopharm Therapeutics (KPTI) 5.2 $81M 4.8M 16.99
Nevro (NVRO) 4.9 $75M 943k 79.85
Urogen Pharma (URGN) 4.8 $74M 1.5M 49.76
Corcept Therapeutics Incorporated (CORT) 4.7 $73M 4.6M 15.72
Exelixis (EXEL) 4.5 $69M 3.2M 21.52
United Therapeutics Corporation (UTHR) 4.1 $64M 567k 113.15
NuVasive 3.7 $57M 1.1M 52.12
Gw Pharmaceuticals Plc ads 3.3 $51M 364k 139.54
Verastem 3.2 $49M 7.2M 6.88
Pacific Biosciences of California (PACB) 2.9 $45M 13M 3.55
D Stemline Therapeutics 2.8 $44M 2.7M 16.05
Luminex Corporation 2.7 $43M 1.4M 29.53
Uniqure Nv (QURE) 2.5 $40M 1.0M 37.80
Vericel (VCEL) 2.3 $35M 3.6M 9.70
Savara (SVRA) 2.0 $31M 2.7M 11.32
Oxford Immunotec Global 1.9 $30M 2.3M 12.89
Adma Biologics (ADMA) 1.2 $19M 4.2M 4.51
Catalyst Pharmaceutical Partners (CPRX) 1.2 $19M 6.0M 3.12
Amarin Corporation (AMRN) 1.0 $15M 5.0M 3.09
Sesen Bio 0.9 $15M 7.5M 1.95
Ra Pharmaceuticals 0.9 $15M 1.5M 9.95
Cardiovascular Systems 0.6 $9.9M 305k 32.34
Biosante Pharmaceuticals (ANIP) 0.6 $9.5M 143k 66.80
Flexion Therapeutics 0.4 $5.6M 217k 25.85